T1	Participants 239 425	Subjects in the Optic Neuritis Treatment Trial, who were enrolled between July 1, 1988, and June 30, 1991, were followed up prospectively for 15 years, with the final examination in 2006
T2	Participants 435 498	Neurologic and ophthalmologic examinations at 13 clinical sites
